FDA Approved: FENOFIBRATE — Supplemental Application (Apotex Corp.)

View source ↗

Summary

The FDA approved Apotex Corp.'s supplemental application for fenofibrate (generic) under ANDA 202252.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Dyslipidemia
• Hyperlipidemia
• Hypertriglyceridemia

Drugs mentioned

• Fenofibrate (generic) (fenofibrate)

Snippet

SUPPL AP for FENOFIBRATE (FENOFIBRATE)